What pregnancy-related risk is associated with starting an antipsychotic?

What pregnancy-related risk is associated with starting an antipsychotic?

• A. Increased fetal risk
• B. No pregnancy-related risks
• C. Illness relapse and poor prenatal care
• D. Decreased maternal health

Answer: (C)

Starting antipsychotic treatment during pregnancy centers on keeping the mother mentally stable to protect the pregnancy. If the psychiatric illness remains untreated or becomes unstable, relapse is a real risk. A relapse can disrupt prenatal care, lead to poor nutrition, increased stress, or unsafe behaviors, and overall worsen pregnancy outcomes. So the main pregnancy-related risk tied to initiating antipsychotic therapy is illness relapse and the resulting poor prenatal care. While there are considerations about fetal effects of medications, the most relevant consequence in this context is that untreated or unstable maternal illness can derail prenatal care and maternal health.

Starting antipsychotic treatment during pregnancy centers on keeping the mother mentally stable to protect the pregnancy. If the psychiatric illness remains untreated or becomes unstable, relapse is a real risk. A relapse can disrupt prenatal care, lead to poor nutrition, increased stress, or unsafe behaviors, and overall worsen pregnancy outcomes. So the main pregnancy-related risk tied to initiating antipsychotic therapy is illness relapse and the resulting poor prenatal care. While there are considerations about fetal effects of medications, the most relevant consequence in this context is that untreated or unstable maternal illness can derail prenatal care and maternal health.